Free Daily Analysis
Stock Trend Analysis Report
Prepared for you on Saturday, February 22, 2025.
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
Crossroads (+60) - REGN is struggling to move into a solid trend. Beware of choppy markets and consider a sidelines position until a stronger trend is identified.
Is it time to buy, sell, or avoid REGN?
MarketClub looks at technical strength and momentum to determine if the timing is right for REGN.
Learn more about the Trade Triangles and how we make technical analysis as easy as buy and sell.
|
|||||||||||||||
|
|||||||||||||||
MarketClub’s Trade Triangles for REGN
The long-term trend has been DOWN since Oct 4th, 2024 at 1008.41
The intermediate-term trend has been UP since Feb 5th, 2025 at 716.93
The short-term trend has been UP since Feb 14th, 2025 at 680.79
Smart Scan Analysis for REGN
Based on our trend formula, REGN is rated as a +60 on a scale from -100 (Strong Downtrend) to +100 (Strong Uptrend).
| Open | High | Low | Price | Change |
|---|---|---|---|---|
| 697.74 | 704.08 | 693.07 | 700.28 | +4.26 |
| Prev. Close | Volume | Bid | Ask | Time |
| 700.33 | 452882 | 2025-02-21 15:59:59 |
| Year High | 416.49 | Year High Date | 2018-08-30 |
| Year Low | 281.89 | Year Low Date | 2018-05-09 |
| 52wk High | 1211.2 | 52wk High Date | 2024-08-27 |
| 52wk Low | 642 | 52wk Low Date | 2025-02-04 |
| Year End Close | 171.07 | Average Volume | 949,918 |
| Shares Outstanding | 109,325 | Short Interest | 4,273,307 |
| % Institutional | 93.5 | Market Cap | 31,118M |
| Assets | 377,594,000M | Liabilities | 840,580,000M |
| P/E Ratio | 18.1539 | Beta | 0.77 |
| Volatility | 37.15 |